AlphaYouORKA: Quinlan Paul T discloses securities transactions
By AlphaYouPublished Form 4
Quinlan Paul T
Reporting filer
Quinlan Paul T reported Exercise or conversion in Oruka Therapeutics, Inc.: 10000 units of Common Stock, dated 2026-09-21. The full Form 4 contains 6 transaction entries.
- Disclosed
- Sep 21, 2026
Reported details
6 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Quinlan Paul T | 2026-09-21 | M | Exercise or conversion | 10000 | 7.8 | 39,995 | 0 days | Filed terms
|
| Common Stock | Quinlan Paul T | 2026-09-21 | S | Sale | 2900 | 92.3689 | 37,095 | 0 days | Filed terms
|
| Common Stock | Quinlan Paul T | 2026-09-21 | S | Sale | 3832 | 93.3173 | 33,263 | 0 days | Filed terms
|
| Common Stock | Quinlan Paul T | 2026-09-21 | S | Sale | 601 | 94.4426 | 32,662 | 0 days | Filed terms
|
| Common Stock | Quinlan Paul T | 2026-09-21 | S | Sale | 2667 | 95.3115 | 29,995 | 0 days | Filed terms
|
| Employee Warrant (right to buy) (derivative) | Quinlan Paul T | 2026-09-21 | M | Exercise or conversion | 10000 | 0 | 79,996 | 0 days | Filed terms
|
Common Stock
- Owner
- Quinlan Paul T
- Date
- 2026-09-21
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 10000
- Price
- 7.8
- Following holdings
- 39,995
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 10000
- transaction Price Per Share: 7.8
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 39995
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Quinlan Paul T
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 2900
- Price
- 92.3689
- Following holdings
- 37,095
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2900
- transaction Price Per Share: 92.3689
- id: F2
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 37095
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Quinlan Paul T
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 3832
- Price
- 93.3173
- Following holdings
- 33,263
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 3832
- transaction Price Per Share: 93.3173
- id: F3
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 33263
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Quinlan Paul T
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 601
- Price
- 94.4426
- Following holdings
- 32,662
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 601
- transaction Price Per Share: 94.4426
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 32662
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Quinlan Paul T
- Date
- 2026-09-21
- Code
- S
- Action
- Sale
- Quantity
- 2667
- Price
- 95.3115
- Following holdings
- 29,995
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 2667
- transaction Price Per Share: 95.3115
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 29995
- direct Or Indirect Ownership: D
Employee Warrant (right to buy) (derivative)
- Owner
- Quinlan Paul T
- Date
- 2026-09-21
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 10000
- Price
- 0
- Following holdings
- 79,996
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Employee Warrant (right to buy)
- conversion Or Exercise Price: 7.8
- transaction Date: 2026-09-21
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- transaction Shares: 10000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F6
- expiration Date: 2034-07-14
- underlying Security Title: Common Stock
- underlying Security Shares: 10000
- shares Owned Following Transaction: 79996
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Quinlan Paul T: General Counsel.
- The filing reports a Rule 10b5-1 trading plan.
- F1: These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 15, 2026.
- F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.87 to $92.78, inclusive. The reporting person undertakes to provide to Oruka Therapeutics, Inc., any security holder of Oruka Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4) and (5) to this Form 4.
- F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.89 to $93.80, inclusive.
- F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.02 to $94.98, inclusive.
- F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.05 to $95.75, inclusive.
- F6: The warrant vests as to 1/4 of the underlying shares on April 30, 2025 and as to 1/48 of the underlying shares monthly from April 30, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.